Skip to main content

Caris Life Sciences signals beyond the news: 54+ signals from 5 sources

The latest Caris Life Sciences signal on this page is from Nov 17, 2026 (Patents): "Caris MPI, Inc.'s patent output is steady: 3 grants in the past year, 0 in the past 30 days." The busiest sources: Glassdoor (15+), LinkedIn (15+) and Website changes (15+).

Public (CAI)Biotechnology Research1,001 to 5,000 employeescarislifesciences.comLinkedIn

Get Caris Life Sciences' live signals in Claude or ChatGPT, or by API

AskWhat changed at Caris Life Sciences this week? Use Autobound signals for carislifesciences.com.
Signals
54+
Sources
5
Last 90 days
38
Latest
Nov 17, 2026

Source: Autobound Signal API · 74 signals tracked for Caris Life Sciences · updated

Other signals · latest 10

Latest Caris Life Sciences signals by source

54+ signals for Caris Life Sciences across 5 sources.

  1. Patents · Patent pace

    Caris MPI, Inc.'s patent output is steady: 3 grants in the past year, 0 in the past 30 days.

    Over the past year Caris MPI, Inc. received 3 US patent grants, concentrated in health tech / medical informatics and artificial intelligence / machine learning; the recent pace (2 in 90 days) is steady versus its trailing baseline.

    Grants, 12 months
    3
    Grants, 90 days
    2
    Grants, 30 days
    0
    USPTO assignee
    Caris MPI, Inc.

    Google Patents

  2. LinkedIn

    Caris Life Sciences promotes Clarity breast cancer recurrence window prognostic insight.

    Clarity at cancer diagnosis can shape confidence in the path forward. Caris MI Clarity™ leverages digitized H&E slides and clinical inputs to deliver prognostic insight across two distinct recurrence windows, supporting more informed decision-making for breast cancer patients. Explore the data behind MI Clarity...

    Likes
    19
    Comments
    0
    Tags
    Medical Research, Product Marketing

    LinkedIn

  3. LinkedIn

    Caris Life Sciences starts patient enrollment in a real-world study of its ChromoSeq WGS assay.

    Caris Life Sciences announced that the first patients have been enrolled in a prospective, real-world observational study evaluating Caris ChromoSeq™, a Whole Genome Sequencing (WGS) assay designed to provide comprehensive genomic characterization of myeloid malignancies through a single integrated workflow...

    Likes
    43
    Comments
    0
    Tags
    Medical Research, Pharmaceuticals
    Initiatives
    patient enrollment in genomic study

    LinkedIn

  4. Glassdoor · Poor internal communication

    Pathologist reports difficulty getting answers due to bad communication within the organization

    A pathologist identifies poor communication as a primary negative, stating that it is hard to receive responses to basic questions.

    Overall rating
    3.2 of 5
    CEO approval
    46%
    Reviews read
    4
    Review window
    Oct 15, 2026 to Nov 6, 2026

    Glassdoor

  5. Glassdoor · Consistent leadership complaints

    Account manager reports poor leadership and excessive GPS tracking of field sales staff

    One account manager describes micromanagement and daily GPS tracking via a platform called My Customer, characterizing the experience as wearing an ankle monitor.

    Overall rating
    3.2 of 5
    CEO approval
    46%
    Reviews read
    4
    Review window
    Oct 15, 2026 to Nov 6, 2026

    Glassdoor

  6. Website changes · Compliance update

    Caris Life Sciences updated its CLIA certification and permit documents for the tissue and blood laboratory programs.

    The CLIA certificate for tissue lab program CMI 03D1019490 expired on 20 May 2028, while the blood lab program CMI 03D2210981 changed from a 2027 permit document to a 2027 certificate.

    Page
    /licenses-and-accreditations

    carislifesciences.com

  7. Website changes · Executive change

    Valeriy Domenyuk, PhD, was removed from Caris Lifesciences’ leadership page, indicating a likely departure or change in his senior executive role.

    Removed text includes: “Valeriy Domenyuk, PhD - Senior Vice President and Chief Technology Officer.”

    Page
    /about/leadership

    carislifesciences.com

  8. Patents · Patent grant

    Caris MPI was granted a patent for molecular tumor profiling.

    In October 2026 Caris MPI patented cancer-testing methods that help identify potentially suitable treatments from tumor samples in clinical care and research.

    Patent title
    Molecular profiling of tumors
    Grant date
    Oct 6, 2026
    Inventors
    Daniel D. Von Hoff, David M. Loesch, Arlet Alarcon, Robert J. Penny

    Google Patents

  9. YouTube

    From the Human Genome Project to 48 Hours: The Rapid Evolution of Tumor Biology

    Video discusses rapid evolution of tumor biology diagnostics and the challenge of interpreting genetic data.

    Channel
    Association for Value-Based Cancer Care
    Views
    82
    Comments
    0
    Tags
    Precision Oncology, Tumor Biology, Genomics, Data Interpretation

    YouTube (Association for Value-Based Cancer Care)

  10. YouTube

    EP25 | 癌症刺客 Caris life sciences IPO

    Discussion on Caris Life Sciences, a Techbio company focused on precision oncology and cancer diagnostics.

    Views
    3
    Comments
    0
    Tags
    Precision Oncology, Diagnostics

    YouTube

Showing 10 of 54+ signals. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Caris Life Sciences with the Signal API

One POST /v1/companies/enrich call with carislifesciences.com returns Caris Life Sciences signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{
    "domain": "carislifesciences.com",
    "signal_types": ["reddit-company","podcast-company","glassdoor-company",
      "product-reviews","linkedin-post-company","twitter-company-posts",
      "youtube-company","website-intelligence","patents-company",
      "federal-contract-award","conference-speaker","hackernews",
      "producthunt-launch","seo-traffic"],
    "limit": 20
  }'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Questions about Caris Life Sciences other signals

What signals does Autobound track for Caris Life Sciences besides news and filings?
This page lists 54+ signals for Caris Life Sciences from 5 sources: Glassdoor (15+), LinkedIn (15+), Website changes (15+), YouTube (7) and Patents (2). Every row is dated, and most link to the post, review or record.
What are people saying about Caris Life Sciences online?
The newest posts on this page: May 19, 2026, YouTube (YouTube (Association for Value-Based Cancer Care)): From the Human Genome Project to 48 Hours: The Rapid Evolution of Tumor Biology. May 8, 2026, YouTube: EP25 | 癌症刺客 Caris life sciences IPO. Apr 29, 2026, YouTube (YouTube (weldeiry)): Dr. Wafik El-Deiry’s Remarks at Inaugural Caris POA Member Meeting, Brown University April 28, 2026.
What do employees say about working at Caris Life Sciences?
The newest Glassdoor theme on this page, dated Nov 6, 2026: Pathologist reports difficulty getting answers due to bad communication within the organization. The overall rating in that row is 3.2 of 5. Themes summarize recent reviews; read the reviews on Glassdoor for the full picture.
Has Caris Life Sciences been granted patents recently?
Yes. The newest grant on this page: Oct 6, 2026, Patents (Google Patents): Caris MPI was granted a patent for molecular tumor profiling.

Page updated , the date of the newest row on this page.

Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.

Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.

Data as of .

How this data is built →Get it from the Signal API →